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AbstrAct
Introduction Acute rehabilitation in critically ill patients 
can improve post-intensive care unit (post-ICU) physical 
function. In-bed cycling early in a patient’s ICU stay is a 
promising intervention. The objective of this study was 
to determine the feasibility of recruitment, intervention 
delivery and retention in a multi centre randomised clinical 
trial (RCT) of early in-bed cycling with mechanically 
ventilated (MV) patients.
Methods We conducted a pilot RCT conducted in seven 
Canadian medical-surgical ICUs. We enrolled adults who 
could ambulate independently before ICU admission, 
within the first 4 days of invasive MV and first 7 days 
of ICU admission. Following informed consent, patients 
underwent concealed randomisation to either 30 min/day 
of in-bed cycling and routine physiotherapy (Cycling) or 
routine physiotherapy alone (Routine) for 5 days/week, until 
ICU discharge. Our feasibility outcome targets included: 
accrual of 1–2 patients/month/site; >80% cycling protocol 
delivery; >80% outcomes measured and >80% blinded 
outcome measures at hospital discharge. We report 
ascertainment rates for our primary outcome for the main 
trial (Physical Function ICU Test-scored (PFIT-s) at hospital 
discharge).
results Between 3/2015 and 6/2016, we randomised 66 
patients (36 Cycling, 30 Routine). Our consent rate was 
84.6 % (66/78). Patient accrual was (mean (SD)) 1.1 (0.3) 
patients/month/site. Cycling occurred in 79.3% (146/184) 
of eligible sessions, with a median (IQR) session duration 
of 30.5 (30.0, 30.7) min. We recorded 43 (97.7%) PFIT-s 
scores at hospital discharge and 37 (86.0%) of these 
assessments were blinded.
Discussion Our pilot RCT suggests that a future 
multicentre RCT of early in-bed cycling for MV patients in 
the ICU is feasible.
trial registration number NCT02377830.
IntroDuctIon
Patients surviving critical illness are at risk 
of significant physical disability up to 8 years 
after discharge from the intensive care unit 
(ICU).1 2 Patients admitted to ICU have 
increased morbidity and case complexity, 
and more are surviving after critical illness.3 
In a prospective cohort study of 391 medical 
surgical ICU survivors, function at 7 days 
post-ICU predicted function 1 year later, 
suggesting that rehabilitation interven-
tions initiated during or immediately after 
ICU discharge could improve long term 
outcomes.4
However, important barriers to conducting 
early rehabilitation early in a patient’s ICU 
stay exist, including the presence of an endo-
tracheal tube and the use of vasoactive medi-
cations and continuous sedation.5 In-bed 
cycling started in the ICU can improve phys-
ical function at hospital discharge and is a 
promising early intervention for mechani-
cally ventilated (MV) patients. During cycling, 
patients can transition from passive to active 
cycling, while intubated and receiving vasoac-
tive medications or sedative infusions.6
While several studies document the feasi-
bility or safety6–9 of in-bed cycling, surprisingly 
few randomised clinical trials (RCTs) exist. In 
a 90-patient RCT, those who started cycling 
14 days after ICU admission had farther 6 
min walk test scores at hospital discharge.10 
In an RCT of 21 patients with sepsis, those 
Key messages
 ► Is it feasible and safe to conduct a multicentre pilot 
randomised clinical trial (RCT) of early in-bed cy-
cling with mechanically ventilated (MV) patients with 
frontline physiotherapists?
 ► Our pilot RCT suggests that a multicentre RCT is 
feasible, but strategies to optimise enrolment and 
cycling intervention delivery will be needed.
 ► We outline practical considerations for conducting a 
large RCT of early in-bed cycling with MV patients.
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who received short-term early cycling demonstrated 
preserved muscle fibre cross-sectional area at 7 days.11 In 
a 49-patient RCT, those who started passive cycling 3 days 
after ICU admission had larger improvements in strength 
scores at ICU discharge.12 However, in a recent RCT of 
314 patients that added both in-bed cycling and neuro-
muscular electrical stimulation to early mobilisation in 
critically ill patients did not improve muscle strength at 
ICU discharge.13 The functional impact of early cycling 
alone on MV patients within the first week of ICU admis-
sion has not been evaluated.
Before embarking on a large RCT, a pilot RCT is needed 
for several reasons.14 Despite widespread awareness of 
in-bed cycling, this technology is not commonly available 
in ICUs.15 Previous studies documented important meth-
odological challenges conducting rehabilitation RCTs 
with critically ill patients including suboptimal recruit-
ment,16 17 impaired intervention delivery18 and losses to 
follow-up.19 Our objective was to conduct a pilot RCT to 
assess the feasibility of recruitment, intervention delivery 
and retention to inform a larger RCT.14 20
MethoDs
Our full pilot trial protocol is published elsewhere.21 
Briefly, we included patients who could ambulate inde-
pendently at baseline (with or without a gait aid), within 
the first 4 days of MV and the first 7 days of ICU admis-
sion. The research coordinator started screening patients 
on ICU admission and ascertained patients’ ambula-
tion status based on chart review and/or history from 
the patient or substitute decision maker. We excluded 
patients who could not follow simple commands in 
English at baseline, could not receive cycling (eg, did 
not fit equipment, acute leg fracture), had confirmed or 
suspected neuromuscular weakness per the critical care 
team, had a temporary pacemaker, were not likely to 
survive their hospital stay or had palliative goals of care 
or were pregnant. To ensure that the intervention started 
early, we also excluded those who had temporary exemp-
tions unresolved within the first 4 days of MV (eg, haemo-
dynamic (eg, increasing vasoactive medications, myocar-
dial infarction, uncontrolled arrhythmia, hypotension or 
hypertension, bradycardia or tachycardia) or respiratory 
instability (eg, SpO2<88%, neuromuscular blockers)).
21
Research coordinators obtained written informed 
consent from patients or more commonly, their substi-
tute decision makers, if patients were unable to consent. 
After informed consent was obtained, research coordi-
nators randomised patients using a web-based, comput-
er-generated block randomisation system (http://www. 
randomize. net). We initiated the allocated intervention 
as soon as possible after randomisation. Patients were 
allocated to either 30 min of cycling/day and routine 
physical therapy interventions (Cycling) or routine 
physical therapy interventions (Routine) alone until 
ICU discharge or 28 days, whichever occurred first, and 
regardless of sedation status. When patients randomised 
to cycling could successfully march on the spot for two 
consecutive days, we discontinued cycling and focused on 
more challenging progressive mobility activities.
Our primary feasibility objective was to evaluate our 
ability to conduct blinded assessments of the Phys-
ical Function ICU test-scored (PFIT-s)22 23 at hospital 
discharge, anticipating that this would be the primary 
outcome for a full RCT. Trained physiotherapists (PTs) 
conducted all performance-based measures. Electronic 
online supplementary file 1 describes the two study arms, 
baseline and outcome measures.24 Four further feasibility 
objectives were: (1) accrual of 1–2 patients/month/site; 
(2) >80% cycling protocol delivery; (3)>80% outcomes 
measured and (4) >80% blinded outcome measures at 
hospital discharge.
Analysis
We calculated the 60-patient sample size based on identi-
fying a 0.25 standardised effect size between the two arms 
for the PFIT-s at hospital discharge.21 For binary variables, 
we calculated counts and percentages. For continuous 
variables, we calculated the mean and SD or median and 
IQR, as appropriate. For between-group comparisons, 
we conducted Student’s t-test with 95% CI or Wilcoxon 
Rank Sum test as appropriate. We planned a subgroup 
analysis to assess whether or not there were differences 
in achieving our feasibility objectives for patients ≥65 and 
for those <65 years old, hypothesising that no difference 
would exist. We considered results to be statistically signif-
icant when p≤0.05 and conducted all analyses using SAS 
V.9.4 for Windows (SAS Institute, Cary, North Carolina, 
USA). Local ethics committees approved our research.
results
Between 25/3/2015 and 22/6/2016, we enrolled 
patients in seven Canadian ICUs. Before trial initiation, 
we provided standardised education and onsite training 
on the cycle ergometer to 36 ICU PTs. We enrolled an 
additional 6 patients for a total of 66 patients (36 Cycling 
and 30 routine) to compensate for 2 patients randomised 
to cycling who did not receive any cycling and 2 patients 
who had missing hospital discharge assessments. We 
enrolled two extra patients to maintain trial momentum 
across the sites and ensure we had no additional missing 
hospital discharge assessments.
Accrual
Our consent rate (95% CI) was 84.6% (74.7, 91.8). Our 
mean (SD) enrolment was 1.1 (0.3) patients/month/site 
and 4.1 patients/month overall. Of 256 eligible patients, 
190 (74.2%) were not randomised, primarily due to PT 
capacity (123 (64.7%)). Figure 1 outlines the participant 
flow diagram. Table 1 outlines patient characteristics. 
Table 2 summarises the ICU interventions received by 
both groups.
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Figure 1 Patient flow diagram. Multiple reasons may account for patient exclusions or patients eligible but not randomised. 
ICU, intensive care unit; MV, mechanically ventilated; PFIT-s, Physical Function ICU Test-scored; PT, physiotherapist.
cycling intervention protocol delivery
No patients in the routine group received cycling. Out 
of 36 patients randomised, 34 (94.4%) received cycling. 
The median (IQR) time from ICU admission to initia-
tion of cycling was 3 (2, 5) days. Patients cycled on 146 
(79.3%) of all eligible days, with a median (IQR) delivery 
of 88% (67, 100) per patient. The total median (IQR) 
duration of cycling over the ICU stay/patient was 84 (49, 
182) min. Each patient received a median (IQR) of 3 
(2, 6) cycling sessions, for a median duration of 30 (30, 
31) min per session. Including the bike set-up and take 
down, this required 45 (39, 50) min per session of PT 
time. Two patients did not receive any cycling because 
one marched on the spot for two consecutive days imme-
diately following randomisation, and one had persistent 
exemptions.
Overall, 78.8% (115) of all cycling sessions reached 30 
min. Cycling and routine PT occurred within the same 
session on 94 (64.4%) occasions. Out of 146 sessions, 16 
patients did not reach 30 min in 31 (21.2%) sessions due 
to fatigue (14, 9.6%), patient request (8, 5.5%) or miscel-
laneous reasons (eg, tachycardia, tachypnoea, agitation 
and so on (9, 6.1%)). Table 3 outlines the temporary 
exemptions and reasons why patients did not cycle on 
eligible days.
routine care
Electronic online supplementary file 2 summarises the 
duration and types of routine physiotherapy interventions 
received by both groups. The median (IQR) time from 
ICU admission to initiation of routine physiotherapy was 
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Table 1 Patient demographics and baseline characteristics
Total
N=66
Cycling
N=36
Routine
N=30
Age, mean (SD) 61.6 (16.9) 60.0 (16.8) 63.6 (17.1)
Female, n (%) 26 (39.4) 9 (25.0) 17 (56.7)
Race, n (%)
  White 61 (92.4) 33 (91.7) 28 (93.3)
  Other 5 (7.6) 3 (8.3) 2 (6.7)
Prehospital living status, n (%)
  Home (independent) 47 (71.2) 29 (80.6) 18 (60.0)
  Home (unpaid caregiver assistance) 8 (12.1) 2 (5.6) 6 (20.0)
  Assisted living facility 5 (7.6) 2 (5.6) 3 (10.0)
  Home (home care) 3 (4.5) 1 (2.8) 2 (6.7)
  Retirement home 1 (1.5) 0 1 (3.3)
  Other 3 (4.5) 1 (2.8) 2 (6.7)
APACHE II score, mean (SD) 23.5 (8.6) 24.6 (10.0) 22.1 (6.4)
Medical admission, n (%) 52 (78.8) 29 (80.6) 23 (76.7)
Admission diagnosis, n (%)
  Respiratory 36 (54.5) 18 (50.0) 18 (60.0)
  Sepsis 11 (16.7) 5 (13.9) 6 (20.0)
  Gastrointestinal 8 (12.1) 6 (16.7) 2 (6.7)
  Metabolic 4 (6.1) 4 (11.1) 0
  Cardiovascular/vascular 3 (4.5) 1 (2.8) 2 (6.7)
  Renal 2 (3.0) 1 (2.8) 1 (3.3)
  Neurological 2 (3.0) 1 (2.8) 1 (3.3)
Charlson Comorbidity Index, mean (SD) 1.92 (1.60) 1.94 (1.72) 1.90 (1.47)
Functional Comorbidity Index, mean (SD) 2.32 (2.25) 2.22 (2.46) 2.43 (2.01)
Pre-ICU Katz ADL score, mean (SD) 5.65 (0.98) 5.67 (1.01) 5.63 (0.96)
Pre-ICU Functional Status Score for ICU, mean (SD) 33.2 (4.6) 32.8 (5.1) 33.7 (3.9)
Frailty score before ICU admission, mean (SD) 3.47 (1.68) 3.36 (1.68) 3.60 (1.69)
Location before ICU admission, n (%)
  Emergency room in study hospital 22 (33.3) 12 (33.3) 10 (33.3)
  Hospital ward 19 (28.8) 10 (27.8) 9 (30.0)
  Operating room/ post-operative recovery room 13 (19.7) 6 (16.7) 7 (23.3)
  ICU in other hospital 5 (7.6) 3 (8.3) 2 (6.7)
  Emergency in other hospital 4 (6.1) 4 (11.1) 0
  Other 3 (4.5) 1 (2.8) 2 (6.7)
This table summarises patient demographics, baseline characteristics and patient outcomes. APACHE II is a 13-item instrument with scores 
from 0 to 71, higher scores representing higher severity of illness;37 Charlson Comorbidity Index includes 19 categories of comorbidity, 
with higher scores representing more comorbidity;38 Functional Comorbidity Index includes 18 items associated with physical function, 
with higher scores representing higher comorbid illness;39 Katz score is a 6-item instrument assessing independence in bathing, dressing 
toileting, transferring, continence and feeding, with higher scores representing more independence.40
ADL, activities of daily living; APACHE II, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; SD, standard deviation.
3 (2, 4) days. We identified no differences in the dura-
tion of routine physiotherapy between groups. The total 
median (IQR) duration of routine physiotherapy over the 
ICU stay per patient was 118 (58, 215) min (Cycling=119 
(39, 233); Routine=114 (66, 213)). Each patient received 
a median (IQR) of 5 (3, 9) routine physiotherapy sessions, 
for a median duration of 21 (15, 30) min per session 
(Cycling=20 (7, 31); Routine=23 (17, 30)). Patients 
received routine physiotherapy with a femoral catheter 
in situ on 10 (4.0%) and 26 (13.1%) days in the Cycling 
and Routine groups, respectively. Post-ICU, there was no 
difference in the median (IQR) days of physiotherapy on 
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Table 2 ICU interventions by group
Total Cycling Routine
N=66 N=36 N=30
Mechanical ventilation
  Days of invasive mechanical ventilation, median (IQR), days 8 (5–19) 8.5 (5–17) 8 (5–19)
  Days of ETT airway access, median (IQR), days 7 (5–13) 7 (5–13) 8 (5–13)
  Non-invasive mechanical ventilation, n (%) 9 (13.6) 6 (16.7) 3 (10.0)
  Other advanced ventilation, n (%)* 4 (6.1) 2 (5.6) 2 (6.7)
Other advanced life support
  Vasopressor or inotrope infusion, n (%) 39 (59.1) 24 (66.7) 15 (50.0)
  Renal replacement therapy, n (%) 8 (12.1) 4 (11.1) 4 (13.3)
Infusions
  Opiates, n (%) 44 (66.7) 26 (72.2) 18 (60.0)
  Benzodiazepines, n (%) 24 (36.4) 14 (38.9) 10 (33.3)
  Propofol, n (%) 49 (74.2) 26 (72.2) 23 (76.7)
  Neuromuscular blockers, n (%) 7 (10.6) 2 (5.6) 5 (16.7)
This table summarises ICU exposures received by the Cycling and Routine physical therapy groups.
*Other advanced ventilation includes extracorporeal membrane oxygenation and nitric oxide.
ETT, endotracheal tube; ICU, intensive care unit; IQR, interquartile range.
the wards between group (Cycling=6 (3, 11); Routine=6 
(3, 15)).
Adverse events
In the cycling group, one patient experienced a supraven-
tricular tachycardia in one session requiring early cycling 
termination. Patients biked with a femoral catheter in situ 
on 4 (2.7%) days, with no accidental removals. During 
445 days of routine physiotherapy, 4 patients experienced 
4 (0.80%) adverse events (1 Cycling, 3 Routine): uncon-
trolled arrhythmia (n=2), 1 desaturation to 80% and 1 
elevated heart rate during ambulation (both returned 
to baseline following rest). No further medical follow-up 
was required after these events. In both the Cycling and 
Routine groups, patients did not sustain any myocardial 
ischaemia, unplanned extubations or bleeding at femoral 
catheter sites.
outcome measure assessment
We recorded 43 (97.7%) PFIT-s scores at hospital 
discharge and assessors blinded to treatment allocation 
measured 37 (86.0%). Electronic online supplementary 
file 3 outlines the outcome measures. There was no differ-
ence in PFIT-s score between Cycling and Routine groups 
at any time point. Table 4 summarises patient mortality 
and discharge disposition.
subgroup analysis
We identified no difference in most of our feasibility 
outcomes between those <65 and those ≥65 years: PFIT-s 
outcomes ascertainment at hospital discharge or blinded 
PFIT-s outcomes (data not shown). Cycling delivery was 
13.6% lower in those <65 years (72.1% vs 85.7%).
DIscussIon
Our data suggest it is feasible and safe to conduct a multi-
centre RCT of early in-bed cycling with critically ill MV 
patients; however, frontline PT capacity is an important 
consideration for the full RCT.
considerations for the full rct
We conducted this trial with frontline ICU PTs that 
included study participants as part of their clinical case-
load. PT capacity was a barrier for enrolment due to 
unexpected staffing shortages and limited ability to enrol 
concurrent study patients. Therapist workload accounted 
for missed cycling on 10% of eligible days (table 3). 
These issues highlight important considerations for 
timely enrolment and study completion and for opti-
mising exposure to the cycling intervention in the full 
RCT. Other acute care rehabilitation investigators expe-
rienced similar challenges.25 For example, a multicentre 
study of early stroke rehabilitation reported that staff 
absences due to parental leave led to delayed recruitment 
to achieve the target sample size.25 Potential strategies to 
improve enrolment include increased frontline ICU PT 
staffing or dedicated research ICU PTs for in-bed cycling. 
Further research to understand barriers and facilitators 
of early in-bed cycling from quantitative and qualitative 
perspectives is needed.
Our study highlights the importance of optimising 
rehabilitation on eligible days due to competing priorities 
in the ICU environment. We offered ICU physiotherapy 
6 Kho ME, et al. BMJ Open Resp Res 2019;6:e000383. doi:10.1136/bmjresp-2018-000383
Open access
Table 3 Patients randomised to cycling: temporary 
exemptions, reasons for not cycling on eligible days and 
advanced life support received during cycling
Days with temporary exemptions (n=95) N (%)*
ICU team perception that patient is medically unstable 
for other reasons (eg, uncontrolled bleeding, impending 
intubation)
48 (50.5)
Cardiac 25 (26.3)
  MAP <60 or >110 or out of range 10 (10.5)
  Active myocardial ischaemia or unstable/uncontrolled 
arrhythmia
6 (6.3)
  Increase in inotropes/vasopressors within last 2 hours 5 (5.3)
  HR <40 or >140 bpm 4 (4.2)
Respiratory 12 (12.6)
  Neuromuscular blocker within last 4 hours 7 (7.4)
  SpO2<88% or out of range 5 (5.3)
Other reasons 29 (30.5)
  Change in goals to palliative care 14 (14.7)
  Severe agitation (RASS>2) 8 (8.4)
  Uncontrolled pain 7 (7.4)
Eligible days where cycling did not occur (n=38) N (%)†
Therapist not available—workload 16 (8.7)
Patient declined 14 (7.6)
No CYCLE-trained PT available 2 (1.1)
Other patient activity prioritised 2 (1.1)
Family declined 1 (0.5)
Patient not available—out of ICU or in ICU (procedures, 
tests)
1 (0.5)
Bike not available 1 (0.5)
Missing data 1 (0.5)
Advanced life support received during cycling 
sessions (n=146)
N (%)
Mechanical ventilation 114 (78.1)
  Oral endotracheal tube 98 (67.1)
  Tracheostomy 13 (8.9)
  Non-invasive 3 (2.1)
Days with temporary exemptions (n=95) N(%)*
  Renal replacement therapy 6 (4.1)
  Vasopressor or inotrope infusion 12 (8.2)
*Totals sum greater than 95 because each day could have more than one 
temporary exemption. Data are reasons as a proportion of 95 days.
†Total sum greater than 38 because each day could have more than one 
reason for not cycling. Data are reasons as a proportion of 184 eligible days. 
Of 38 days, 20 (52.6%) patients missed 1 or more eligible days of cycling; 
Therapist factors: 6 (30.0%) patients did not receive cycling due to physical 
therapist workload; 4 (20.0%) patients did not receive cycling because the 
physical therapist prioritised other therapeutic activities; patient factors: 11 
(55.0%) patients declined 1 or more cycling sessions and 2 (10.0%) patients 
did not receive cycling due to other reasons.
bpm, beats per minute; HR, heart rate; ICU, intensive care unit; MAP, mean 
arterial pressure; PT, physiotherapist; RASS, Richmond Agitation and 
Sedation Scale.
5 days per week, consistent with the current ICU thera-
pist staffing models in the majority of our participating 
centres. Cycling and routine rehabilitation occurred 
on 79% and 75% of all eligible days, respectively. While 
the rehabilitation and cycling exposure was modest 
compared with patients’ median 11 day ICU length of 
stay, the optimal timing and dose of rehabilitation inter-
ventions in the ICU is not known.26 Thus, it is critical we 
provide rehabilitation at every possible opportunity. Our 
median duration of 21 min of routine physiotherapy per 
session exceeded reported values in recent RCTs, which 
varied from 7 to 13 min per session.18 27 Potentially modi-
fiable targets to increase cycling exposure or rehabilita-
tion interventions include augmenting therapist capacity, 
different staffing models, improved care coordination 
and strategies to encourage patient engagement.
relationship to previous studies
Recent RCTs of rehabilitation interventions in the 
ICU reported discordant results. These discrepancies 
may be due to challenges with the types of enrolled 
patients (eg, case-mix, or pre-morbid functional status) 
or trial conduct (eg, accrual, intervention delivery, and 
outcome measurement).17–19 28 For example, a single-
centre, 150-patient RCT of intensive exercise started in 
the ICU with medical-surgical patients versus usual care 
demonstrated no difference in 6 min walk test at 1 year.17 
However, this study was stopped before achieving the 
target sample of 200 patients due to lack of funding.17 
A 4-centre, 308-patient RCT of 90 vs 30 min of daily ICU 
rehabilitation demonstrated no difference in quality of 
life at 6 months.18 However, on average, patients did not 
receive the protocol as intended, and the intervention 
and control group only received 23 and 13 min of daily 
rehabilitation, respectively.18 A 5-centre, 120-patient RCT 
of intensive physical therapy versus usual care in patients 
with acute respiratory failure demonstrated no differ-
ence in physical function at 1 month; however, 63% had 
missing primary outcome measures.19 Learning from 
these important studies, our pilot RCT suggests that 
enrolment, intervention delivery and outcome measure-
ment are feasible in our future large RCT.
A landmark early rehabilitation study randomised 106 
patients to early occupational and physiotherapy inter-
ventions within 1.5 days of MV compared with routine 
care, which started at 7.4 days post-ICU admission.29 More 
patients randomised to early rehabilitation were function-
ally independent at hospital discharge, compared with 
those who were not (59% vs 35%, p=0.02). In contrast, 
a recent study of early intensive versus standard rehabili-
tation found no difference in physical components score 
at 6 months; however, investigators did not successfully 
implement the intervention as described above.18 Other 
studies of early rehabilitation interventions demonstrated 
no differences in hospital length of stay30 or function.31 32 
Similar to previous RCTs,27–32 few adverse events occurred 
during either of our early rehabilitation interventions, 
despite very different approaches to early rehabilitation.
Two international, multicentre RCTs studied early goal 
directed mobilisation (EGDM) in surgical28 and medi-
cal-surgical ICU patients.27 EGDM involves targeting a 
daily specific mobility goal, led by PTs in consultation 
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Table 5 Three primary modifications for the main CYCLE RCT
Item Modification
1. Enrolment  ► Increase frontline ICU PT staffing or identify dedicated research ICU PTs for in-bed cycling.
2. Intervention delivery  ► To increase cycling exposure or rehabilitation interventions, consider augmenting therapist 
capacity, different staffing models, improved care coordination, and strategies to encourage 
patient engagement.
 ► Conduct further research to understand barriers and facilitators of early in-bed cycling from 
quantitative and qualitative perspectives.
3. Primary outcome  ► Conduct the PFIT-s post ICU discharge rather than at hospital discharge to evaluate the 
effect of cycling on more survivors closely following their ICU discharge.
This table summarises key modifications for the main CYCLE RCT based on lessons learned from the pilot RCT.
ICU, intensive care unit; PFIT-S, Physical Function ICU Test-scored; PT, physiotherapist; RCT, randomised clinical trial.
Table 4 Patient outcomes
Outcome ICU discharge Hospital discharge
Cycling Routine Cycling Routine
Mortality, n (%) 9 (25.0) 9 (30.0) 11 (30.6) 11 (36.7)
Length of stay, median (IQR) days 13.5 (7.5–25.5) 10 (9–24) 27 (13.5–47) 25 (19–45)
Clinical Frailty Score, mean (SD) 5.0 (1.7) 5.3 (1.7)
Hospital disposition for survivors, N 
(%) (N=44)
N=25 N=19
  Home—independent 11 (44.0) 6 (31.6)
  Home—home care 3 (12.0) 4 (21.1)
  Home—unpaid caregiver 2 (8.0) 4 (21.1)
  Inpatient rehabilitation 5 (20.0) 2 (10.5)
  Other hospital 3 (12.0) 2 (10.5)
  Other 1 (4.0) 1 (5.3)
This table summarised patients’ outcomes post-ICU.
ICU, intensive care unit; IQR, interquartile range; SD, standard deviation.
with the ICU multidisciplinary team. In a 5-centre RCT, 
200 postsurgical ICU patients were randomised to EGDM 
facilitated by a dedicated critical care staff member versus 
standard care. Those receiving EGDM (n=104) achieved 
higher ICU mobility levels and had better functional 
mobility at hospital discharge than those who did not.28 
In the 5-centre, 50-patient unblinded TEAM pilot RCT, 
those randomised to EGDM (n=29) achieved higher ICU 
mobility score levels at ICU discharge33 and longer dura-
tion of therapy (median (IQR) 20 (0–40) vs 7 (0–15) min 
per day)) than those randomised to usual care. The full 
TEAM RCT to study the effects of early mobilisation on 
the primary outcome of the number of days alive and out 
of hospital is currently underway (NCT03133377)
As anticipated in this pilot trial focused on feasibility 
metrics,14 we did not identify any between group differ-
ences. From ICU awakening to hospital discharge, 
patients’ strength, function and quality of life improved. 
However, patients still demonstrated important disability 
at hospital discharge. For example, patients completed a 
median of 5 sit to stand repetitions at hospital discharge. 
This value falls well below that of the lowest average 
normative value of 14 repetitions in 80–90-year-old 
community dwelling women.34 Similarly, the median 
2 min walk test distances varied from 76 m (cycling) to 
61 m (routine), which are much lower than the lowest 
normative value of 134.3 m in 80–85-year-old women.35 
Our patients may require ongoing outpatient rehabilita-
tion interventions to improve their function. Over 60% 
of all of our survivors required some assistance posthos-
pital discharge (table 4).
limitations and strengths
This study was not designed to evaluate the effect of 
cycling on patient-important outcomes due to the pilot 
trial design and attendant sample size. We did not proto-
colise routine physical therapy or sedation because at the 
time of trial design, there was no consensus on optimal 
implementation of either intervention.36 We originally 
planned to use this trial as an internal pilot with blinded 
PFIT-s measures at hospital discharge;21 however as we 
concluded our trial, the Towards RECOVER study iden-
tified the prognostic importance of physical function 
measures at 7 days post-ICU and function 1 year later.4 
Thus, for the future RCT, we will conduct the primary 
8 Kho ME, et al. BMJ Open Resp Res 2019;6:e000383. doi:10.1136/bmjresp-2018-000383
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outcome measure 3 days post ICU discharge rather than 
at hospital discharge to evaluate the effect of cycling on 
more survivors closely following their ICU discharge.
Strengths of this study include evaluation of a PT-led 
intervention in seven ICUs, underscoring the importance 
of an interprofessional approach to rehabilitation. We 
engaged the largest number of centres and conducted 
the largest multiprofessional trial of early in-bed cycling 
in the field to-date. Randomisation was concealed. This 
was an unblinded trial in conduct, but blinded outcome 
ascertainment was performed for 86% of patients. There 
was no contamination of control patients receiving 
cycling. Table 5 highlights three key revisions for the 
main RCT.
conclusIon
In-bed cycling is a promising early intervention for MV 
patients to improve physical function. Our pilot RCT 
suggests that a multicentre RCT is feasible but strategies 
to optimise enrolment and cycling intervention delivery 
will be needed. Lessons learnt through this pilot trial 
have informed the vanguard phase of a large multicentre 
CYCLE trial of early rehabilitation in critically ill patients 
using in-bed cycling, now underway (NCT02377830).
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